On Sept. 3, 2020, BioMedomics announced that the Therapeutic Goods Administration, a branch of the Department of Health in the Australian Government, had provided the company authorization to sell and distribute the Sickle SCANﾮ rapid test in Australia.

The company partnered with Helena Laboratories Australia to assist with distributing the product to customers.